Jinyu Bio-Technology subsidiary obtains new swine vaccine registration

Jinyu Bio-Technology announced its subsidiaries received a new veterinary drug registration certificate for an inactivated porcine parvovirus vaccine.

Registered as a Class III new veterinary drug, the vaccine prevents porcine parvovirus disease and provides immunity for up to 7 months. This development strengthens the company's position in the animal vaccine sector.